Literature DB >> 14514350

Inhibition of insulin secretion via distinct signaling pathways in alpha2-adrenoceptor knockout mice.

Melanie Peterhoff1, Andrea Sieg, Marc Brede, Cho-Ming Chao, Lutz Hein, Susanne Ullrich.   

Abstract

OBJECTIVE: Adrenaline inhibits insulin secretion through activation of alpha(2)-adrenoceptors (ARs). These receptors are linked to pertussis toxin-sensitive G proteins. Agonist binding leads to inhibition of adenylyl cyclase, inhibition of Ca(2+) channels and activation of K(+) channels. Recently, three distinct subtypes of alpha(2)-AR were described, alpha(2A)-AR, alpha(2B)-AR and alpha(2C)-AR. At present, it is unknown which of these alpha(2)-AR subtype(s) may regulate insulin secretion. We used mice deficient in alpha(2)-ARs to analyze the coupling and role of individual alpha(2)-AR subtypes in insulin-secreting beta cells.
METHODS: The inhibitory effect of adrenaline on insulin secretion was measured in freshly isolated and cultured wild type (wt) and alpha(2)-AR knockout (KO) mouse islets in order to examine the receptor subtypes which mediate adrenaline-induced inhibition of insulin secretion. Adenylyl cyclase activity was measured in isolated cultured islets. Membrane potential was measured using the amphotericin B permeabilized patch clamp method in isolated and cultured single islet cells.
RESULTS: In wt, alpha(2A)- and alpha(2C)-AR KO mouse islets, adrenaline, 1 microM/L, inhibited secretion by 83, 80 and 100% respectively. In contrast, in alpha(2A/2C)-AR double KO mouse islets, adrenaline had no effect on stimulated secretion indicating that both alpha(2A)-AR and alpha(2C)-AR, but not alpha(2B)-AR, are functionally expressed in mouse islets. Surprisingly, glucose (16.7 mM/L)-induced secretion in the presence of 1 microM/L forskolin was greatly impaired in alpha(2A)-AR KO islets. However, when cAMP levels were increased further by the combination of forskolin (5 microM/L) and 3-isobutyl-1-methylxanthine (100 microM/L), secretion was stimulated 2.7-fold (8.5-fold in wt islets). Adrenaline lowered the concentration of cAMP in wt and alpha(2C)-AR KO mouse islets by 74%. Adrenaline also hyperpolarized wt and alpha(2C)-AR KO beta cells. In contrast, adrenaline did not inhibit adenylyl cyclase in islets of alpha(2A)-AR KO mice, nor did it hyperpolarize alpha(2A)-AR KO beta cells.
CONCLUSION: Adrenaline inhibits insulin release through alpha(2A)- and alpha(2C)-ARs via distinct intracellular signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14514350     DOI: 10.1530/eje.0.1490343

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  28 in total

1.  Leucine stimulates insulin secretion via down-regulation of surface expression of adrenergic α2A receptor through the mTOR (mammalian target of rapamycin) pathway: implication in new-onset diabetes in renal transplantation.

Authors:  Jun Yang; Michael Dolinger; Gabrielle Ritaccio; Joseph Mazurkiewicz; David Conti; Xinjun Zhu; Yunfei Huang
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

2.  Enhanced insulin secretion responsiveness and islet adrenergic desensitization after chronic norepinephrine suppression is discontinued in fetal sheep.

Authors:  Xiaochuan Chen; Alice S Green; Antoni R Macko; Dustin T Yates; Amy C Kelly; Sean W Limesand
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-11-19       Impact factor: 4.310

3.  Effects of dexmedetomidine on insulin secretion from rat pancreatic β cells.

Authors:  Tetsuya Takahashi; Takashi Kawano; Satoru Eguchi; Haidong Chi; Hideki Iwata; Masataka Yokoyama
Journal:  J Anesth       Date:  2014-11-07       Impact factor: 2.078

Review 4.  Evolving insights regarding mechanisms for the inhibition of insulin release by norepinephrine and heterotrimeric G proteins.

Authors:  Susanne G Straub; Geoffrey W G Sharp
Journal:  Am J Physiol Cell Physiol       Date:  2012-04-04       Impact factor: 4.249

5.  Chronic exposure to elevated norepinephrine suppresses insulin secretion in fetal sheep with placental insufficiency and intrauterine growth restriction.

Authors:  Rafael A Leos; Miranda J Anderson; Xiaochuan Chen; Juliana Pugmire; K Arbor Anderson; Sean W Limesand
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-01-19       Impact factor: 4.310

6.  Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors.

Authors:  Anne-Julie Chabot-Doré; Magali Millecamps; Lina Naso; Dominic Devost; Phan Trieu; Marjo Piltonen; Luda Diatchenko; Carolyn A Fairbanks; George L Wilcox; Terence E Hébert; Laura S Stone
Journal:  Neuropharmacology       Date:  2015-08-06       Impact factor: 5.250

7.  Systemic metabolic derangement, pulmonary effects, and insulin insufficiency following subchronic ozone exposure in rats.

Authors:  Desinia B Miller; Samantha J Snow; Andres Henriquez; Mette C Schladweiler; Allen D Ledbetter; Judy E Richards; Debora L Andrews; Urmila P Kodavanti
Journal:  Toxicol Appl Pharmacol       Date:  2016-06-28       Impact factor: 4.219

8.  Repurposing cAMP-modulating medications to promote β-cell replication.

Authors:  Zhenshan Zhao; Yen S Low; Neali A Armstrong; Jennifer Hyoje Ryu; Sara A Sun; Anthony C Arvanites; Jennifer Hollister-Lock; Nigam H Shah; Gordon C Weir; Justin P Annes
Journal:  Mol Endocrinol       Date:  2014-08-01

9.  alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.

Authors:  V Fagerholm; M Scheinin; M Haaparanta
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

Review 10.  Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes.

Authors:  Bo Ahrén
Journal:  Nat Rev Drug Discov       Date:  2009-04-14       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.